Beam Therapeutics Statistics
NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
20.90-0.04 (-0.19%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Beam Therapeutics by the numbers
Beam Therapeutics has a market capitalization of $2.16 billion based on 103.50M shares outstanding. With trailing EPS of $-0.87, Beam Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.2% below its 50-day average and 24.6% below its 200-day average.
Average daily trading volume is 2.04M shares, or about $42.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BEAM valuation vs. peer median
| Metric | BEAM | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.16B | $1.72B | +26% |
| Avg. volume | 2.04M | 1.79M | +14% |
Peer median across 8 companies: BCRX, COAG, REPL, LYCA, MAZE, VIR, RXRX, ALVO.
Valuation
- Market cap
- $2.16B
- Price / sales (latest FY)
- 15.48
- EPS (TTM)
- $-0.87
- Shares outstanding
- 103.50M
Price and trading
- Previous close
- 20.94
- Open
- 20.54
- Day range
- 20.54 – 22.10
- 52-week range
- 20.44 – 38.26
- 52-week change
- -5.90%
- Beta
- —
- Volume
- 3.88M
- Average volume
- 2.04M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 2.16B
- Forward Pe
- -4.05
- Eps
- -0.87
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 38.26
- Week52 Low
- 20.44
- Avg Volume
- 2.04M
- Shares Outstanding
- 103.50M
- Ma50
- 24.63
- Ma200
- 27.72
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -45.37%
- Pct From52w Low
- 2.25%